BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25231973)

  • 1. Raloxifene inhibits cloned Kv4.3 channels in an estrogen receptor-independent manner.
    Chae YJ; Kim DH; Lee HJ; Sung KW; Kwon OJ; Hahn SJ
    Pflugers Arch; 2015 Aug; 467(8):1663-76. PubMed ID: 25231973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of MiRP1 and DPP6 beta-subunits on the blockade induced by flecainide of Kv4.3/KChIP2 channels.
    Radicke S; Vaquero M; Caballero R; Gómez R; Núñez L; Tamargo J; Ravens U; Wettwer E; Delpón E
    Br J Pharmacol; 2008 Jun; 154(4):774-86. PubMed ID: 18536731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional modulation of the transient outward current Ito by KCNE beta-subunits and regional distribution in human non-failing and failing hearts.
    Radicke S; Cotella D; Graf EM; Banse U; Jost N; Varró A; Tseng GN; Ravens U; Wettwer E
    Cardiovasc Res; 2006 Sep; 71(4):695-703. PubMed ID: 16876774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mosapride on Kv4.3 potassium channels expressed in CHO cells.
    Sung KW; Hahn SJ
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Oct; 386(10):905-16. PubMed ID: 23793103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Kv4.3 by genistein via a tyrosine phosphorylation-independent mechanism.
    Kim HJ; Ahn HS; Choi BH; Hahn SJ
    Am J Physiol Cell Physiol; 2011 Mar; 300(3):C567-75. PubMed ID: 21148405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of haloperidol on Kv4.3 potassium channels.
    Lee HJ; Sung KW; Hahn SJ
    Eur J Pharmacol; 2014 Oct; 740():1-8. PubMed ID: 24998874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Block of cloned Kv4.3 potassium channels by dapoxetine.
    Jeong I; Kim SW; Yoon SH; Hahn SJ
    Neuropharmacology; 2012 Jun; 62(7):2261-6. PubMed ID: 22192593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of ropivacaine with cloned cardiac Kv4.3/KChIP2.2 complexes.
    Friederich P; Solth A
    Anesthesiology; 2004 Dec; 101(6):1347-56. PubMed ID: 15564942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Block of Kv4.3 potassium channel by trifluoperazine independent of CaMKII.
    Chae YJ; Choi BH; Choi JS; Hahn SJ
    Neurosci Lett; 2014 Aug; 578():159-64. PubMed ID: 24993295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Kv4.3 voltage-dependent gating kinetics by KChIP2 isoforms.
    Patel SP; Parai R; Parai R; Campbell DL
    J Physiol; 2004 May; 557(Pt 1):19-41. PubMed ID: 14724186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone inhibits Kv4.3 potassium channels by open-channel block and acceleration of closed-state inactivation.
    Jeong I; Choi BH; Hahn SJ
    Br J Pharmacol; 2011 Jun; 163(3):510-20. PubMed ID: 21232039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ranolazine on cloned cardiac kv4.3 potassium channels.
    Kim HJ; Ahn HS; Choi JS; Choi BH; Hahn SJ
    J Pharmacol Exp Ther; 2011 Dec; 339(3):952-8. PubMed ID: 21940646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of polyunsaturated fatty acids on Kv4/KChIP potassium channels.
    Boland LM; Drzewiecki MM; Timoney G; Casey E
    Am J Physiol Cell Physiol; 2009 May; 296(5):C1003-14. PubMed ID: 19261906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the transient outward current (Ito) in rat cardiac myocytes and human Kv4.3 channels by mefloquine.
    Perez-Cortes EJ; Islas AA; Arevalo JP; Mancilla C; Monjaraz E; Salinas-Stefanon EM
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):203-12. PubMed ID: 26216464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine blocks cloned Kv4.3 potassium channels.
    Choi JS; Hahn SJ
    Brain Res; 2012 Jul; 1466():15-23. PubMed ID: 22618310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Kv4.3 potassium channels by trazodone.
    Chae YJ; Choi JS; Hahn SJ
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):711-9. PubMed ID: 23615873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of K
    de Benito-Bueno A; Socuellamos PG; Merinero YG; Cercos P; Izquierdo C; Daniel-Mozo M; Marín-Olivero I; Perez-Lara A; Gonzalez-Vera JA; Orte A; Albert A; Martin-Martinez M; Gutierrez-Rodriguez M; Valenzuela C
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.
    Kim SE; Ahn HS; Choi BH; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    J Pharmacol Exp Ther; 2007 May; 321(2):753-62. PubMed ID: 17312186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of human Kv4.3/KChIP2 channel inactivation kinetics by cytoplasmic Ca
    Groen C; Bähring R
    Pflugers Arch; 2017 Nov; 469(11):1457-1470. PubMed ID: 28735419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of riluzole with the closed inactivated state of Kv4.3 channels.
    Ahn HS; Kim SE; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    J Pharmacol Exp Ther; 2006 Oct; 319(1):323-31. PubMed ID: 16815868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.